217 related articles for article (PubMed ID: 32948223)
1. Long-term analysis of multimodality treatment outcomes and prognosis of esthesioneuroblastomas: a single center results of 138 patients.
Sun M; Wang K; Qu Y; Zhang J; Zhang S; Chen X; Wang J; Wu R; Zhang Y; Yi J; Xiao J; Xu G; Huang X; Luo J
Radiat Oncol; 2020 Sep; 15(1):219. PubMed ID: 32948223
[TBL] [Abstract][Full Text] [Related]
2. Management of orbital invasion in esthesioneuroblastoma: 14 years' experience.
Li R; Tian S; Zhu Y; Yan L; Zhu W; Quan H; Wang S
Radiat Oncol; 2019 Jun; 14(1):107. PubMed ID: 31196122
[TBL] [Abstract][Full Text] [Related]
3. Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients.
Xiong L; Zeng XL; Guo CK; Liu AW; Huang L
BMC Cancer; 2017 Apr; 17(1):254. PubMed ID: 28399835
[TBL] [Abstract][Full Text] [Related]
4. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and outcomes of multimodality treatment in olfactory neuroblastoma.
Song X; Wang J; Wang S; Yan L; Li Y
Oral Oncol; 2020 Apr; 103():104618. PubMed ID: 32126517
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of patients with esthesioneuroblastomas: A cohort from a single institution.
Yin ZZ; Gao L; Luo JW; Yi JL; Huang XD; Qu Y; Wang K; Zhang SP; Xiao JP; Xu GZ; Li YX
Oral Oncol; 2016 Feb; 53():48-53. PubMed ID: 26712253
[TBL] [Abstract][Full Text] [Related]
7. Optimization of long-term outcomes for patients with esthesioneuroblastoma.
Ow TJ; Hanna EY; Roberts DB; Levine NB; El-Naggar AK; Rosenthal DI; DeMonte F; Kupferman ME
Head Neck; 2014 Apr; 36(4):524-30. PubMed ID: 23780581
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic factors and outcome of esthesioneuroblastoma].
Zhao LJ; Gao L; Xu GZ; Li SY; Xiao GL
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):561-4. PubMed ID: 16438858
[TBL] [Abstract][Full Text] [Related]
9. [Long-term experiences in the therapy of esthesioneuroblastoma].
Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Prognostic Analysis after Endoscopic Endonasal Surgery for Olfactory Neuroblastoma: A Retrospective Study of 13 Cases.
Zhang L; Niu K; Zhu K; Xia C; Yan J; Zhao W; Wei J; Duan M; Zheng G
PLoS One; 2016; 11(11):e0166046. PubMed ID: 27806104
[TBL] [Abstract][Full Text] [Related]
11. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?
Eich HT; Müller RP; Micke O; Kocher M; Berthold F; Hero B
Strahlenther Onkol; 2005 Jun; 181(6):378-84. PubMed ID: 15925980
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Kadish staging in esthesioneuroblastoma: An analysis of the National Cancer Database.
Konuthula N; Iloreta AM; Miles B; Rhome R; Ozbek U; Genden EM; Posner M; Misiukiewicz K; Govindaraj S; Shrivastava R; Gupta V; Bakst RL
Head Neck; 2017 Oct; 39(10):1962-1968. PubMed ID: 28815831
[TBL] [Abstract][Full Text] [Related]
13. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
Ozsahin M; Gruber G; Olszyk O; Karakoyun-Celik O; Pehlivan B; Azria D; Roelandts M; Kaanders JH; Cengiz M; Krengli M; Matzinger O; Zouhair A
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):992-7. PubMed ID: 20231062
[TBL] [Abstract][Full Text] [Related]
14. Multimodality Treatment of Pediatric Esthesioneuroblastoma.
Venkatramani R; Pan H; Furman WL; Marron JM; Haduong J; Friedrich-Medina P; Mahajan A; Bavle A; Wu H; Chintagumpala M
Pediatr Blood Cancer; 2016 Mar; 63(3):465-70. PubMed ID: 26514449
[TBL] [Abstract][Full Text] [Related]
15. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.
Bell D; Saade R; Roberts D; Ow TJ; Kupferman M; DeMonte F; Hanna EY
Head Neck Pathol; 2015 Mar; 9(1):51-9. PubMed ID: 24806334
[TBL] [Abstract][Full Text] [Related]
16. [A retrospective study about 11 cases of Esthesioneuroblastomas treated in Hospital Santa Creu i Sant Pau between 2000 and 2008 and literature review].
Muñoz F; Tresserras P; Montserrat JR; Sancho FJ; Bartumeus F
Neurocirugia (Astur); 2011 Oct; 22(5):401-17; discussion 417-8. PubMed ID: 22031159
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of 31 cases of esthesioneuroblastoma].
He X; Wang Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Apr; 35(4):338-340. PubMed ID: 33794633
[No Abstract] [Full Text] [Related]
18. Esthesioneuroblastoma in children and adolescent: experience on 11 cases with literature review.
El Kababri M; Habrand JL; Valteau-Couanet D; Gaspar N; Dufour C; Oberlin O
J Pediatr Hematol Oncol; 2014 Mar; 36(2):91-5. PubMed ID: 24390450
[TBL] [Abstract][Full Text] [Related]
19. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.
Mori T; Onimaru R; Onodera S; Tsuchiya K; Yasuda K; Hatakeyama H; Kobayashi H; Terasaka S; Homma A; Shirato H
Radiat Oncol; 2015 Apr; 10():88. PubMed ID: 25888953
[TBL] [Abstract][Full Text] [Related]
20. Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome.
Malouf GG; Casiraghi O; Deutsch E; Guigay J; Temam S; Bourhis J
Eur J Cancer; 2013 Apr; 49(6):1324-34. PubMed ID: 23312882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
